Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2023-12-19 Regulatory Filings
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and contains details of shareholders and share certificates. This is a regulatory announcement related to share certificate status and does not contain financial statements, management discussion, or other report content. It is not a report itself but a regulatory filing informing the exchange of a specific event. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement rather than a report.
2023-12-19 English
We submit herewith disclosure of Consent to Establish received for DACL Fine Chem Limited, Wholly Owned Subsidiary of the Company.
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the receipt of a Consent to Establish (CTE) from the Gujarat Pollution Control Board for a subsidiary's new plant. It references compliance with SEBI Regulation 30, which mandates disclosure of material events. The content is an announcement of a regulatory approval (license) granted, not a financial report or detailed analysis. The document length is short (3734 characters) and primarily serves as a regulatory update. It does not contain financial statements, management discussion, or detailed report data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2023-12-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the receipt of a Consent to Establish (CTE) from the Gujarat Pollution Control Board for a subsidiary's new plant. It references compliance with SEBI Regulation 30, which mandates disclosure of material events. The content is about regulatory approval and licensing, not financial results, management changes, or shareholder votes. The document length is 3734 characters, which is relatively short and primarily an announcement of a regulatory approval event. It does not contain financial statements or detailed reports. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-18 English
We submit herewith details of loss of share certificates as per Regulation 39(3) of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplaced/non-receipt of share certificates and the process of issuing duplicate share certificates. It is addressed to stock exchanges and involves share certificate details and shareholder information. There is no financial data, earnings information, or report attached or referenced. The document is a regulatory announcement related to share certificates and compliance with listing obligations, not a financial report or management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-16 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and is a regulatory compliance announcement related to share certificates. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about share certificate status and issuance, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-16 English
We submit herewith details of loss of share certificates as per regulation 39(3) of SEBI (LODR) Regulations, 2015.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and is a regulatory compliance announcement. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory filing informing about share certificate status and related procedural updates. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2044 characters), and it is not a report or announcement of a report publication but a compliance notification.
2023-12-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.